Literature DB >> 33619558

Therapeutic options in VEXAS syndrome: insights from a retrospective series.

Estelle Bourbon1, Maël Heiblig2, Mathieu Gerfaud Valentin3, Thomas Barba4, Cécile-Audrey Durel4, Jean Christophe Lega5,6, Fiorenza Barraco2, Pascal Sève3, Yvan Jamilloux3, Pierre Sujobert1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33619558     DOI： 10.1182/blood.2020010177

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  19 in total

Review 1.  Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT.

Authors:  Carmelo Gurnari; Donal P McLornan
Journal:  Bone Marrow Transplant       Date:  2022-08-08       Impact factor: 5.174

Review 2.  Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.

Authors:  Camila Andrea Guerrero-Bermúdez; Andrés Felipe Cardona-Cardona; Edwin Jesús Ariza-Parra; Juan Ignacio Arostegui; Anna Mensa-Vilaro; Jordi Yague; Gloria Vásquez; Carlos Horacio Muñoz-Vahos
Journal:  Clin Rheumatol       Date:  2022-08-20       Impact factor: 3.650

Review 3.  Somatic mutations in rheumatological diseases: VEXAS syndrome and beyond.

Authors:  Keith A Sikora; Kristina V Wells; Ertugrul Cagri Bolek; Adrianna I Jones; Peter C Grayson
Journal:  Rheumatology (Oxford)       Date:  2022-08-03       Impact factor: 7.046

4.  Adverse Reaction to COVID-19 mRNA Vaccination in a Patient With VEXAS Syndrome.

Authors:  Giulio Ciprian
Journal:  Cureus       Date:  2022-03-24

Review 5.  VEXAS syndrome.

Authors:  Peter C Grayson; Bhavisha A Patel; Neal S Young
Journal:  Blood       Date:  2021-07-01       Impact factor: 25.476

6.  Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease.

Authors:  Fabian Lötscher; Luca Seitz; Helena Simeunovic; Adela-Cristina Sarbu; Naomi A Porret; Laurence Feldmeyer; Luca Borradori; Nicolas Bonadies; Britta Maurer
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

7.  Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience.

Authors:  Ava Diarra; Nicolas Duployez; Elise Fournier; Claude Preudhomme; Valérie Coiteux; Leonardo Magro; Bruno Quesnel; Maël Heiblig; Pierre Sujobert; Fiorenza Barraco; Marie Balsat; Quentin Scanvion; Eric Hachulla; David Launay; Ibrahim Yakoub-Agha; Louis Terriou
Journal:  Blood Adv       Date:  2022-02-08

8.  Thrombosis in VEXAS syndrome.

Authors:  Thet Mon Oo; Jie Tian Jeanette Koay; Siew Fen Lee; Shang Ming Samuel Lee; Xin Rong Lim; Bingwen Eugene Fan
Journal:  J Thromb Thrombolysis       Date:  2021-11-24       Impact factor: 2.300

9.  USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still's Disease in Elderly Patients.

Authors:  Marion Delplanque; Achille Aouba; Pierre Hirsch; Pierre Fenaux; Julie Graveleau; Florent Malard; Damien Roos-Weil; Nabil Belfeki; Louis Drevon; Artem Oganesyan; Matthieu Groh; Matthieu Mahévas; Jerome Razanamahery; Gwenola Maigne; Matthieu Décamp; Sébastien Miranda; Thomas Quemeneur; Julien Rossignol; Laurent Sailler; Marie Sébert; Louis Terriou; Anna Sevoyan; Yervand Hakobyan; Sophie Georgin-Lavialle; Arsène Mekinian
Journal:  J Clin Med       Date:  2021-11-27       Impact factor: 4.241

10.  Dominance of an UBA1 mutant clone over a CALR mutant clone: from essential thrombocytemia to VEXAS.

Authors:  Mehdi Hage-Sleiman; Sophie Lalevée; Hélène Guermouche; Fabrizia Favale; Michael Chaquin; Maxime Battistella; Jean-David Bouaziz; Martine Bagot; François Delhommeau; Florence Cordoliani; Pierre Hirsch
Journal:  Haematologica       Date:  2021-12-01       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.